Your browser doesn't support javascript.
loading
New insights into the genetic basis of premature ovarian insufficiency: Novel causative variants and candidate genes revealed by genomic sequencing.
Jaillard, Sylvie; Bell, Katrina; Akloul, Linda; Walton, Kelly; McElreavy, Kenneth; Stocker, William A; Beaumont, Marion; Harrisson, Craig; Jääskeläinen, Tiina; Palvimo, Jorma J; Robevska, Gorjana; Launay, Erika; Satié, Anne-Pascale; Listyasari, Nurin; Bendavid, Claude; Sreenivasan, Rajini; Duros, Solène; van den Bergen, Jocelyn; Henry, Catherine; Domin-Bernhard, Mathilde; Cornevin, Laurence; Dejucq-Rainsford, Nathalie; Belaud-Rotureau, Marc-Antoine; Odent, Sylvie; Ayers, Katie L; Ravel, Célia; Tucker, Elena J; Sinclair, Andrew H.
Afiliação
  • Jaillard S; Univ Rennes, CHU Rennes, INSERM, EHESP, IRSET (Institut de recherche en santé, environnement et travail) - UMR_S 1085, F-35000, Rennes, France; CHU Rennes, Service de Cytogénétique et Biologie Cellulaire, F-35033, Rennes, France; Murdoch Children's Research Institute, Royal Children's Hospital, Melb
  • Bell K; Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, VIC, 3052, Australia.
  • Akloul L; CHU Rennes, Service de Génétique Clinique, CLAD Ouest, F-35033, Rennes, France.
  • Walton K; Department of Physiology, Monash Biomedicine Discovery Institute, Monash University, VIC, 3800, Australia.
  • McElreavy K; Institut Pasteur, CNRS - UMR_3738, Paris, France.
  • Stocker WA; Department of Physiology, Monash Biomedicine Discovery Institute, Monash University, VIC, 3800, Australia; Department of Chemistry and Biotechnology, Swinburne University of Technology, Hawthorn, VIC, 3122, Australia.
  • Beaumont M; CHU Rennes, Service de Cytogénétique et Biologie Cellulaire, F-35033, Rennes, France.
  • Harrisson C; Department of Physiology, Monash Biomedicine Discovery Institute, Monash University, VIC, 3800, Australia.
  • Jääskeläinen T; Institute of Biomedicine, University of Eastern Finland, Kuopio, FI-70211 Kuopio, Finland.
  • Palvimo JJ; Institute of Biomedicine, University of Eastern Finland, Kuopio, FI-70211 Kuopio, Finland.
  • Robevska G; Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, VIC, 3052, Australia.
  • Launay E; CHU Rennes, Service de Cytogénétique et Biologie Cellulaire, F-35033, Rennes, France.
  • Satié AP; Univ Rennes, CHU Rennes, INSERM, EHESP, IRSET (Institut de recherche en santé, environnement et travail) - UMR_S 1085, F-35000, Rennes, France.
  • Listyasari N; Doctoral Program of Medical and Health Sciences, Faculty of Medicine, Diponegoro University, Semarang, Indonesia.
  • Bendavid C; INRAE, INSERM, Univ Rennes, Institut NuMeCan, Rennes, Saint-Gilles, France; CHU Rennes, Laboratoire de Biochimie et Toxicologie, F-35033, Rennes, France.
  • Sreenivasan R; Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, VIC, 3052, Australia.
  • Duros S; CHU Rennes, Département de Gynécologie Obstétrique et Reproduction Humaine, F-35033, Rennes, France.
  • van den Bergen J; Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, VIC, 3052, Australia.
  • Henry C; CHU Rennes, Service de Cytogénétique et Biologie Cellulaire, F-35033, Rennes, France.
  • Domin-Bernhard M; CHU Rennes, Département de Gynécologie Obstétrique et Reproduction Humaine, F-35033, Rennes, France.
  • Cornevin L; CHU Rennes, Service de Cytogénétique et Biologie Cellulaire, F-35033, Rennes, France.
  • Dejucq-Rainsford N; Univ Rennes, CHU Rennes, INSERM, EHESP, IRSET (Institut de recherche en santé, environnement et travail) - UMR_S 1085, F-35000, Rennes, France.
  • Belaud-Rotureau MA; Univ Rennes, CHU Rennes, INSERM, EHESP, IRSET (Institut de recherche en santé, environnement et travail) - UMR_S 1085, F-35000, Rennes, France; CHU Rennes, Service de Cytogénétique et Biologie Cellulaire, F-35033, Rennes, France; CHU Rennes, Service de Biologie de la Reproduction-CECOS, F-35033, Ren
  • Odent S; CHU Rennes, Service de Génétique Clinique, CLAD Ouest, F-35033, Rennes, France; Univ Rennes, CNRS UMR 6290, Institut de Génétique et Développement, F-35000, Rennes, France.
  • Ayers KL; Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, VIC, 3052, Australia; Department of Paediatrics, University of Melbourne, Melbourne, VIC, 3052, Australia.
  • Ravel C; Univ Rennes, CHU Rennes, INSERM, EHESP, IRSET (Institut de recherche en santé, environnement et travail) - UMR_S 1085, F-35000, Rennes, France; CHU Rennes, Service de Biologie de la Reproduction-CECOS, F-35033, Rennes, France.
  • Tucker EJ; Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, VIC, 3052, Australia; Department of Paediatrics, University of Melbourne, Melbourne, VIC, 3052, Australia. Electronic address: elena.tucker@mcri.edu.au.
  • Sinclair AH; Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, VIC, 3052, Australia; Department of Paediatrics, University of Melbourne, Melbourne, VIC, 3052, Australia.
Maturitas ; 141: 9-19, 2020 Nov.
Article em En | MEDLINE | ID: mdl-33036707
ABSTRACT
Ovarian deficiency, including premature ovarian insufficiency (POI) and diminished ovarian reserve (DOR), represents one of the main causes of female infertility. POI is a genetically heterogeneous condition but current understanding of its genetic basis is far from complete, with the cause remaining unknown in the majority of patients. The genes that regulate DOR have been reported but the genetic basis of DOR has not been explored in depth. Both conditions are likely to lie along a continuum of degrees of decrease in ovarian reserve. We performed genomic analysis via whole exome sequencing (WES) followed by in silico analyses and functional experiments to investigate the genetic cause of ovarian deficiency in ten affected women. We achieved diagnoses for three of them, including the identification of novel variants in STAG3, GDF9, and FANCM. We identified potentially causative FSHR variants in another patient. This is the second report of biallelic GDF9 and FANCM variants, and, combined with functional support, validates these genes as bone fide autosomal recessive "POI genes". We also identified new candidate genes, NRIP1, XPO1, and MACF1. These genes have been linked to ovarian function in mouse, pig, and zebrafish respectively, but never in humans. In the case of NRIP1, we provide functional support for the deleterious nature of the variant via SUMOylation and luciferase/ß-galactosidase reporter assays. Our study provides multiple insights into the genetic basis of POI/DOR. We have further elucidated the involvement of GDF9, FANCM, STAG3 and FSHR in POI pathogenesis, and propose new candidate genes, NRIP1, XPO1, and MACF1, which should be the focus of future studies.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Insuficiência Ovariana Primária / Receptores Citoplasmáticos e Nucleares / Carioferinas / Reserva Ovariana / Proteína 1 de Interação com Receptor Nuclear / Proteínas dos Microfilamentos Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Female / Humans Idioma: En Revista: Maturitas Ano de publicação: 2020 Tipo de documento: Article País de publicação: IE / IRELAND / IRLANDA

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Insuficiência Ovariana Primária / Receptores Citoplasmáticos e Nucleares / Carioferinas / Reserva Ovariana / Proteína 1 de Interação com Receptor Nuclear / Proteínas dos Microfilamentos Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Female / Humans Idioma: En Revista: Maturitas Ano de publicação: 2020 Tipo de documento: Article País de publicação: IE / IRELAND / IRLANDA